Potential mucolytic agents for mucinous ascites from pseudomyxoma peritonei.

Abstract

Pseudomyxoma peritonei is a disease characterised by the accumulation of mucinous ascites. Thus far, cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has been shown to be effective at eradicating disease. Chemotherapy has been less effective, providing disease stabilization but not demonstrating significant treatment responses. Mucolytic is a potential class of drug that may be exploited in the chemical management of this disease. A variety of potential mucolytic agents are explored in this review providing evidence of basic biochemical evidence of its efficacy with potential translational application.

• Authors: Krishna Pillai, Javed Akhter, Terence C Chua, David L Morris
• Journal: Investigational new drugs (Invest New Drugs) Vol. 30 Issue 5 Pg. 2080-6 (Oct 2012) ISSN: 1573-0646 [Electronic] United States
• PMID: 22359216 (Publication Type: Journal Article, Review)

Chemical References

• Expectorants

Topics

• Animals
• Ascites (drug therapy)
• Expectorants (therapeutic use)
• Humans
• Peritoneal Neoplasms (drug therapy, surgery)
• Pseudomyxoma Peritonei (drug therapy, surgery)